Study Title
Analysis of Total Busulfan Exposure for Once Daily Intravenous Dosing in Paediatric Haematopoietic Stem Cell Transplantation- An ANZCHOG Pilot Study
Protocol ID
Bu4Day-PK-2016
Disease (Sub Disease)
Haematopoietic Stem Cell Transplant
Diagnosis Stage
Newly diagnosed
Relapsed/refractory
Relapsed/refractory
Location
NSW, QLD, WA
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
Collaborators
Queensland Health- SERTA Grant
University of Queensland
University of Queensland
Links
Trial Status
Open
Sites
Perth Children's Hospital
Sydney Children's hospital
Queensland Children's Hospital
Sydney Children's hospital
Queensland Children's Hospital
Study Type
Observational
Phase
Pilot
Age Eligibility
up to 18 years
ANZCTR
ACTRN12617000227392
| Study Title | Analysis of Total Busulfan Exposure for Once Daily Intravenous Dosing in Paediatric Haematopoietic Stem Cell Transplantation- An ANZCHOG Pilot Study |
|---|---|
| Protocol ID | Bu4Day-PK-2016 |
| Disease (Sub Disease) | Haematopoietic Stem Cell Transplant |
| Diagnosis Stage | Newly diagnosed Relapsed/refractory |
| Location | NSW / QLD / WA |
| Sponsor | Australian and New Zealand Children's Haematology Oncology Group |
| Collaborators | Queensland Health- SERTA Grant/ University of Queensland |
| Links | https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=372251&isReview=true |
| Trial Status | Open |
| Trial Open Date | 29/05/2017 |
| Sites | Perth Children's Hospital / Sydney Children's hospital / Queensland Children's Hospital |
| Study Type | Observational |
| Phase | Pilot |
| Age Eligibility | up to 18 years |
| ANZCTR | ACTRN12617000227392 |